![Samuel Moed](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Samuel Moed
Director/Board Member at
BIONDVAX PHARMACEUTICALS LTD
Net worth: - $ as of 29/09/2026
Profile
Samuel J.
Moed is currently Director at Scinai Immunotherapeutics Ltd. since 2020.
Formerly, Mr. Moed was Senior VP-Strategic Planning & Analysis at Bristol Myers Squibb Co. from 2005 to 2020.
Other former roles include Independent Director at MediWound Ltd., President at US Pharmaceuticals, Inc., and President at Worldwide Consumer Health Care.
Education includes an undergraduate degree from The Trustees of Columbia University in The City of New York, conferred in 1985.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/03/2026 | 0 ( -.--% ) | - $ | 29/09/2026 |
Samuel Moed active positions
| Companies | Position | Start |
|---|---|---|
| BIONDVAX PHARMACEUTICALS LTD | Director/Board Member | 23/03/2020 |
aMoon Ventures Y Sh Ltd.
 aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures invests in companies located in Israel. The firm focuses on life-sciences, biopharma, digital health and medical technology companies. It provides financing for early and late stage capital requirements with an investment size of USD 10 - 30 million. The firm makes follow-on investments and also acts as lead investor. | Private Equity Investor | 31/12/2019 |
Former positions of Samuel Moed
| Companies | Position | End |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 31/12/2019 |
US Pharmaceuticals, Inc.
 US Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines | President | - |
Worldwide Consumer Health Care | President | - |
| MEDIWOUND LTD. | Director/Board Member | - |
Education of Samuel Moed
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
97
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MediWound Ltd.
 MediWound Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes bio-therapeutic solutions for tissue repair and regeneration | Health Technology |
Scinai Immunotherapeutics Ltd.
 Scinai Immunotherapeutics Ltd. Pharmaceuticals: OtherHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes immunomodulation therapies for infectious diseases | Health Technology |
US Pharmaceuticals, Inc.
US Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines | Health Technology |
Worldwide Consumer Health Care | |
aMoon Ventures Y Sh Ltd.
aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures invests in companies located in Israel. The firm focuses on life-sciences, biopharma, digital health and medical technology companies. It provides financing for early and late stage capital requirements with an investment size of USD 10 - 30 million. The firm makes follow-on investments and also acts as lead investor. | Finance |
- Stock Market
- Insiders
- Samuel Moed
